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ABSTRACT  33 
Loss of cell polarity is a fundamental process in cell transformation. Among polarity proteins, we 34 
focused on human Disc Large (DLG1), which is localized mainly at adherens junctions and 35 
contributes to the control of cell proliferation. We previously demonstrated that its expression is 36 
altered in HPV-associated cervical neoplastic lesions, but the mechanisms beyond this remain 37 
unknown. In this study, we analyzed the contribution of HPV proteins to the changes in DLG1 38 
expression in the squamous epithelium. We observed tissue and intracellular misdistribution of DLG1 39 
when high-risk HPV-18 E7 or E6/E7 proteins were expressed in organotypic raft cultures. The viral 40 
oncoproteins induce the loss of DLG1 from the cell borders and an increase in the level of DLG1 41 
protein, reflecting the pattern observed in cervical lesions. These findings were corroborated in 42 
cultures bearing the entire HPV-18 genome. Interestingly, changes in tissue distribution and 43 
abundance of DLG1 were also detected in organotypic cultures expressing the low-risk HPV-11 E7 44 
or E6/E7 proteins; suggesting a conserved function among different HPV types. However, for low-45 
risk HPVs, the subcellular localization of DLG1 at cell-to-cell contacts was predominantly 46 
maintained. This report offers new evidence of the involvement of HPV proteins in DLG1 expression 47 








Human Disc large 1 (DLG1) is a modular scaffolding protein bearing different protein interaction 54 
modules, including the PSD-95⁄DLG⁄ZO-1 (PDZ) domains that allow multiprotein complexes 55 
formation (Lue et al., 1994, Roberts et al., 2012). DLG1 is able to assemble different proteins into 56 
signal transduction networks where DLG1 has structural and signaling functions. DLG1 functions in 57 
controlling cell polarity were first shown in Drosophila, where it was also demonstrated to be a 58 
regulator of cell proliferation. Besides, functional loss of DLG1 has been associated with neoplastic 59 
transformation (Bilder, 2004). In mammalian epithelial cells, DLG1 localizes in the cytoplasm and at 60 
sites of cell contacts in association with adherens junctions (Laprise et al., 2004), being part of the 61 
Scribble polarity complex, which is crucial for the establishment and maintenance of apicobasal 62 
polarity (Assemat et al., 2008).  63 
Most of DLG1 biological functions rely on its ability to interact with several regulatory proteins such 64 
as protein 4.1/ERM family members (Lue et al., 1994), several kinases (Gaudet et al., 2000, Sabio et 65 
al., 2005, Gaudet et al. 2011) and two important tumour suppressors: phosphatase and tensin homolog 66 
(PTEN) and Adenomatous polyposis coli (APC) (Sotelo et al., 2012). Remarkably, the DLG1:APC 67 
binding is important for the negative regulation of cell growth (Ishidate et al., 2000) and the 68 
interaction with PTEN is required for PTEN stability, cooperating with the inactivation of the 69 
proliferative pathways (Sotelo et al., 2012; Valiente et al., 2005). DLG1 was shown to have a dual 70 
role in the regulation of both cell polarity and proliferation, highlighting that tissue polarity and cell 71 
cycle should be fine-tuned linked processes during tumour suppression.  72 
Several reports using human biopsies have described changes in DLG1 abundance and distribution 73 
during malignant progression (Facciuto et al., 2012). Interestingly, while a marked reduction of DLG1 74 
levels in poorly differentiated tumours was described, over-expression and changes in DLG1 75 
distribution at earlier stages of cervical, colon and breast cancers have been observed by different 76 
groups  (Watson et al., 2002; Cavatorta et al., 2004; Fuja et al., 2004; Gardiol et al., 2006). 77 
Importantly, the loss of DLG1 expression at cell contacts during neoplastic progression has been 78 
consistently reported in studies using histological samples. It has been suggested that the intracellular 79 
localization of DLG1 is critical for its biological functions, most likely because the precise 80 
distribution of DLG1 may define the probable interacting partners, implying the orchestration of 81 
different specific signalling pathways.  82 
However, the molecular mechanisms responsible for such alterations, the contribution of high DLG1 83 
expression to tumour prognosis and the precise temporal de-regulation of this protein at different 84 
stages of cancer progression are not fully understood. Besides, despite the fact that DLG1 has been 85 
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postulated as a tumor suppressor some paradoxical data indicate that, under certain conditions, it may 86 
have oncogenic activities (Frese et al., 2006; Krishna Subbaiah et al., 2012).  87 
Cervical cancer is a common malignancy, etiologically associated with infection by a group of Human 88 
papillomavirus (HPV) types. Previous studies have shown a striking DLG1 over-expression in the 89 
cervical precursor squamous intraepithelial lesions (SIL). In these samples DLG1 was lost from cell 90 
contacts and re-distributed to the cytoplasm, especially in the high grade SIL (HSIL) (Watson et al., 91 
2002; Cavatorta et al., 2004).  92 
The continuous expression of the two main HPV oncoproteins, E6 and E7, is important for tumor 93 
progression and maintenance of the transformed phenotype. One of the reported oncogenic activities 94 
of E6 from high-risk HPV types is its capacity to interact with a select group of PDZ domain-95 
containing proteins, including DLG1, through the C-terminal class 1 PDZ binding motif (PBM) (X-96 
S/T-X-V/L) (Gardiol et al., 1999; Pim et al., 2012). This interaction results in DLG1 protein 97 
degradation and/or alteration of subcellular distribution, depending on the experimental conditions 98 
and HPV type. However, the real contribution of HPV proteins to changes in DLG1 expression, 99 
mainly in the context of HPV infection of the squamous epithelia, remains to be established. In this 100 
context, it will be interesting to verify E7 influence on cell polarity proteins expression. E7 has been 101 
proposed as the main HPV oncogene and several reports show its ability to interact and interfere with 102 
a large number of factors that regulate cell proliferation, gene expression and cytoskeleton 103 
organization. For instance, E7 can induce changes in the expression of E-cadherin, a key protein 104 
involved in the formation of adherens junctions and epithelial polarity establishment (Caberg et al., 105 
2008; Hellner et al., 2009).  106 
As mentioned, an integrated picture of the mechanisms controlling DLG1 expression is lacking. 107 
Therefore, a better understanding of the phenomena involved could be relevant considering the 108 
changes in DLG1 levels observed in cervical lesions (Cavatorta et al., 2004). In the present study we 109 
analyzed the effect of HPV oncoproteins to changes in DLG1 expression levels and cell distribution 110 
in epithelial organotypic raft cultures of keratinocytes expressing HPV E7 and HPV E6/E7 proteins 111 
from high- and low- risk HPV types. 112 
Using this system, we observed that cultures expressing HPV-18 E7 or E6/E7 exhibited a 113 
misdistribution of DLG1 throughout the tissue thickness. The presence of the viral proteins also 114 
induced DLG1 loss from cell borders to the cytoplasm, reflecting the expression pattern observed in 115 
SIL biopsies. In addition, E7 and E6/E7 from HPV-18 increased DLG1 levels. Our observations were 116 
corroborated in organotypic cultures of keratinocytes transfected with HPV-18 full-length genome. 117 
Interestingly, changes in DLG1 distribution and abundance were also detected in raft cultures 118 
expressing the low-risk HPV-11 E7 or E6/E7 proteins, although to a lesser extent. This suggests a 119 
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conserved mechanism among HPV types associated with different pathologies. In the case of cultures 120 
expressing the low-risk viral proteins, however, DLG1 subcellular localization at cell contacts was 121 
predominantly maintained. This report offers new evidence concerning HPV proteins involvement in 122 
DLG1 expression pattern, and our data support previous observations regarding DLG1 expression in 123 
cervical lesions. 124 
 125 
RESULTS 126 
HPV-18 oncoproteins interfere with the pattern of DLG1 expression in organotypic raft 127 
cultures. 128 
We first analyzed DLG1 expression pattern in the context of the squamous epithelium in the presence 129 
or absence of the HPV-18 E7 or E6/E7 oncoproteins. We focused on HPV-18 since DLG1 was shown 130 
to be a preferential target for this virus (Thomas et al., 2008). Therefore, we generated organotypic 131 
cultures from primary human keratinocytes (PHK) previously infected with retroviral vectors 132 
expressing E7 or E6/E7. Raft cultures obtained from PHK were used as a control (Fig. 1a). A section 133 
of each paraffinized organotypic culture was stained with haemaetoxilin-eosine, in order to analyze 134 
the morphology of the tissue (Fig. 1a). As expected, the presence of E7 or E6/E7 was associated with 135 
the thickening of the stratified cell layers. Nuclei retention throughout the epithelium including the 136 
uppermost layers was also observed, as previously reported (Delury et al., 2013). The expression of 137 
the HPV-18 genes was determined by RT-PCR (Fig. 1b). In addition, the functionality of the viral 138 
proteins was assessed by evaluating the expression of E7 and E6 cellular targets: retinoblastoma (Rb) 139 
and p53. E7 expression induces a reduction of Rb and an increase in p53 protein levels as described 140 
previously (Fig. 1c) (Thomas & Laimins, 1998; Seavey et al., 1999; Flores et al., 2000, Munger et 141 
al., 2001). p53 expression slightly decreased in E6/E7 expressing rafts when compared to the E7 rafts 142 
and in relation to the loading control (Fig. 1c) (Flores et al., 2000). The effect of the viral proteins 143 
was also corroborated by immunohistochemistry (IHC) on sections of the rafts cultures. The results 144 
presented in Fig. S1 clearly indicate the expression and functionality of both viral proteins.  145 
Our data indicate that in control tissues DLG1 was expressed mainly in the basal and parabasal layers 146 
of the epithelium but was absent in the uppermost differentiated cellular strata. DLG1 was localized 147 
preferentially in the cytoplasm of the basal cells, but in the suprabasal areas it was predominantly 148 
present at cell contacts (Fig. 1d). Isolated nuclei of some epithelial cells showed positive staining, 149 
especially in the basal layer. This observation is in agreement with the DLG1 pattern previously 150 
reported in normal cervical samples (Cavatorta et al., 2004). 151 
For organotypic cultures expressing HPV oncoproteins the overall intracellular staining for DLG1 152 
was more intense compared to control samples. In this case, DLG1 expression was observed 153 
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throughout the epithelial strata. Besides, DLG1 cell localization was cytoplasmic in the basal as well 154 
as in the uppermost layers, where DLG1 at intercellular contacts was reduced (Fig. 1d). This effect 155 
was more striking in samples expressing both E6 and E7, where DLG1 expression at the cell borders 156 
was greatly diminished; interestingly, an increase in nuclear staining was also observed. Remarkably, 157 
these findings are similar to DLG1 expression in SIL (Cavatorta et al., 2004). 158 
Our results demonstrate that HPV-18 E7 can induce changes in DLG1 distribution along the 159 
squamous epithelium and in the subcellular localization, these effects being more marked when both 160 
HPV-18 E6 and E7 proteins are expressed together.  161 
In order to confirm our results, DLG1 expression pattern was analyzed within the context of the whole 162 
HPV genome, using raft cultures established from PHK bearing full-length HPV-18 genome (FK18B) 163 
at passage 27, which morphologically resemble mild dysplasia in vivo (Steenbergen et al., 1998). 164 
DLG1 staining was much more intense comparing to the control, and, in agreement with the data 165 
presented for the E6/E7 cultures, it was expressed throughout the epithelium thickness with a 166 
predominant cytoplasmic distribution and loss from cell contacts (Fig. 2).  167 
 168 
HPV-18 E7 protein induces an increase in the levels of DLG1 169 
In addition to changes in DLG1 distribution by HPV-18 E7 or E6/E7, a slight change in DLG1 170 
abundance could be also appreciated (Fig. 1d). In order to apply a more quantitative assay, we 171 
analyzed DLG1 levels by Western Blotting (WB) using protein extracts from the organotypic 172 
cultures. HPV-18 E7 and E6/E7 proteins induce an increase in DLG1 levels compared to control 173 
samples (Fig. 3a). This raise could be due to the fact that in tissues expressing the HPV proteins, 174 
DLG1 expression extends throughout all the cell strata, while it was only present in the less 175 
differentiated layers in the control (Fig. 1d). Considering this, we evaluated if the presence of E7 176 
could be involved in the up-regulation of DLG1 intracellular levels, independently of the tissue 177 
context. For this, DLG1 abundance was analyzed by WB using protein extracts from HEK293 cells 178 
transiently transfected with plasmids expressing HPV-18 proteins. RT-PCR assays were used to 179 
confirmed viral gene expression (Fig. S2). In these experimental conditions HPV-18 E6 was shown 180 
to promote the degradation of DLG1 in a PBM-dependent manner (Gardiol et al., 1999; Pim et al., 181 
2012). However, it is important to understand the regulation of PDZ proteins in the context of HPV 182 
infection where both oncoproteins are expressed together. As observed in Fig. 3b, E7 alone or together 183 
with E6 results in a moderate increase in DLG1 protein level, in agreement with the observations 184 
obtained using the organotypic cultures and, apparently, overriding the reported effects of E6-185 




Expression of low-risk HPV E7 and E6/E7 proteins also alter DLG1 expression in squamous 188 
raft cultures. 189 
In several neoplastic lesions, tissue disorganization has been associated with alterations in DLG1 190 
expression pattern (Facciuto et al., 2012). However, there are no data about possible changes in 191 
lesions associated to low-risk HPV that, even linked to benign lesions that rarely progress to 192 
malignancy, cause cell hyper proliferation and aberrant differentiation (Jian et al., 1999; Cheng et al., 193 
1995; McCord et al., 2014). We analyzed the effects of E7 and E6/E7 proteins derived from low-risk 194 
HPV-11 on DLG1 expression in organotypic cultures. PHK were infected with retroviral vectors 195 
expressing HPV-11 E7 or E6/E7. In tissues expressing the HPV-11 proteins, the epithelium was 196 
thicker than that from control cultures, due to an increased number of cell layers in the spinous stratum 197 
(Fig. 4a). However, the morphological alterations were less evident than in cultures expressing high-198 
risk HPV proteins (Fig. 1a). The expression of the HPV-11 genes was assessed by RT-PCR (Fig. 4b). 199 
Then, DLG1 immunostaining was evaluated and, interestingly, some changes were observed when 200 
the low-risk HPV proteins were expressed (Fig. 4c). There was a general increase in DLG1 abundance 201 
and its expression was also detected in the uppermost strata. However, DLG1 was present at high 202 
levels at cell borders, especially in the samples were only E7 was expressed. Besides, only a moderate 203 
reduction of DLG1 at that precise cell localization was observed in the E6/E7 expressing samples. In 204 
both conditions an increased in the cytoplasmic DLG1 expression could also be appreciated. 205 
Our data suggest that low-risk HPV also induce a redistribution of DLG1 along the squamous 206 
epithelium but did not markedly alter the subcellular localization at the cell contacts, as when high-207 
risk HPV proteins are expressed. 208 
We next evaluated whether the presence of the HPV-11 E7 and E6/E7 produce a change in DLG1 209 
abundance by WB. As can be seen, the protein extracts derived from organotypic cultures expressing 210 
HPV-11 E7 exhibited a slight increase in DLG1, and this effect was more striking for those samples 211 
where HPV-11 E6 and E7 were present (Fig. 5a).  212 
In order to study the potential effect of HPV-11 proteins on DLG1 levels within the cell, we performed 213 
experiments using transiently transfected HEK293 cells with expression plasmids for the viral 214 
proteins. The expression of the viral sequences was tested by RT-PCR (Fig. S2). As known, the 215 
presence of HPV-11 E6 alone do not change DLG1 levels, since low-risk E6 proteins cannot bind 216 
and degrade the PDZ DLG1 protein (Gardiol et al., 1999). As can be seen in Fig. 5b, the presence of 217 
HPV-11 E7 and E6/E7 also induces an increase in DLG1 levels. 218 
The overall data suggest that low- and high-risk HPV share a conserved mechanism leading to 219 
changes in DLG1 expression levels that should be important for virus replication. This idea points 220 
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out the hypothesis that common functions of E7 or E6/E7 proteins among low- and high-risk HPVs 221 
might participate in molecular pathways that induce these changes. 222 
 223 
Discussion 224 
In this study, we describe the changes in DLG1 expression in the presence of HPV proteins. Several 225 
studies demonstrated alterations in DLG1 abundance and localization during malignant progression, 226 
although it is not clear whether these alterations are a cause or a consequence of the neoplastic 227 
hyperproliferation. In order to better understand the complex pattern of DLG1 expression, we 228 
analyzed this in a model that is relevant for HPV infection and the associated lesions. As HPV life 229 
cycle is entirely dependent on the epithelium differentiation, we set up organotypic cultures that in 230 
vitro mimic the tissue structure. 231 
The presence of HPV-18 E7 or E6/E7 proteins induces a change in tissue and cell distribution of 232 
DLG1 when compared to control cultures. Our results clearly resemble DLG1 expression patterns 233 
observed in HPV-associated SIL (Cavatorta et al., 2004). In the presence of viral proteins, DLG1 was 234 
expressed throughout the thickness of the epithelium, in contrast to control cultures where it was 235 
absent in the uppermost differentiated cells. HPV E7 or E6/E7 expression is expected to alter the 236 
epithelium differentiation program. Therefore, regarding the differentiation status, cells that compose 237 
the tissue strata might not be equivalent to those present in the control tissue. HPV E6 and E7 238 
oncogenes have been shown to disturb the differentiation schedule of the host cell  (Pei et al., 1998; 239 
Zehbe et al., 2009). Moreover, it was recently reported that E6 and/or E7 from high-risk HPVs are 240 
able to down-regulate the expression of differentiation genes (Gyongyosi et al., 2012). This would be 241 
important for viral cycle, inducing the cellular replication machinery in differentiated keratinocytes. 242 
In this sense, HPV-18 E6/E7 induced the expression of the cell cycle and proliferation markers: cyclin 243 
A and proliferating cell nuclear antigen (PCNA) in the epithelium suprabasal layers (Fig. S3), as 244 
described previously (Flores eta al., 2000; Wang et al., 2009). Although differences in cell cycle 245 
activity may contribute to DLG1 altered expression observed in organotypic cultures, our results do 246 
not rule out the involvement of other mechanisms, as discussed below. 247 
One of the interesting features shown in Fig. 1d is the clear reduction of DLG1 at cell contacts while 248 
the staining increased in the cytoplasm in presence of HPV-18 proteins. Our results indicate a possible 249 
role of the HPV proteins in DLG1 changes observed for HPV-associated neoplasias (Watson, 2002; 250 
Cavatorta, 2004). In fact, the accumulation of DLG1 in the cytoplasm may have an oncogenic 251 
significance since it was shown that specific cellular pools of DLG1 in the presence of viral 252 
oncoproteins could have oncogenic functions (Frese et al., 2006; Krishna Subbaiah et al., 2012).   253 
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Several studies demonstrated that E6 can interact and induce the proteasome-mediated degradation 254 
of DLG1; however, this degradation involves specific subcellular pools. Furthermore, degradation 255 
seems to be incomplete since significant levels remain in HPV cancer cell lines and certain pools of 256 
DLG1 are actively maintained by the continuous expression of E6/E7 (Krishna Subbaiah et al., 2012). 257 
In a recent study it was shown that the residual cytoskeletal-bound forms of DLG1 influences RhoG 258 
activity by making a complex with SGEF and this association is maintained by the presence of E6 259 
and E7 oncoproteins. These cooperative functions between E6 and E7, promoting the activity of 260 
RhoG, a protein which has been involved in cell proliferation and differentiation, could be useful for 261 
virus replication in the tissue context (Krishna Subbaiah et al., 2012). These observations may 262 
contribute to explain the data shown in Fig. 1d, where a considerable amount of DLG1 is maintained 263 
in the cytoplasm perhaps complexed with cell proteins involved in cell growth.  264 
E7 expression in epithelial cells was demonstrated to cause a drop in the levels of the adhesion protein 265 
E-cadherin, which is involved in DLG1 localization at cell contacts (Reuver and Garner, 1998; 266 
Hellner et al., 2009). This may account for the slight decrease in DLG1 immunostaining at cell 267 
borders in the presence of HPV-18 E7. Moreover, DLG1 reduction at cell contacts was more striking 268 
in E6/E7 cultures. Therefore, it is possible to speculate that E6 could contribute to DLG1 down-269 
regulation, perhaps by preferentially targeting those DLG1 forms for degradation (Massimi et al., 270 
2006).   271 
At present, it is not possible to discard that other mechanisms induced by the presence of the viral 272 
oncoproteins could also promote changes in DLG1 protein binding capacity, stimulating its 273 
interaction with different partners that redirect its localization. This is consistent with the hypothesis 274 
that diverse DLG1 pools may have different functions and, possibly, opposite activities regarding the 275 
malignant progression. 276 
It is important to highlight that the presence of E6/E7 also promotes an increase in DLG1the nuclear 277 
localization. It was shown that in conditions where cell polarity can be altered, cell junction proteins 278 
are disassembled and can migrate to the nucleus and regulate transcriptional activity (Polette et al., 279 
2005). Moreover, Narayan and colleagues (2009) have shown that DLG1 nuclear localization is 280 
highly dependent on phosphorylation by cycling kinases during cell cycle progression, and high-risk 281 
HPV oncoproteins are known to promote cell cycle entry even in differentiated cells (Fig. S3).  282 
Moreover, changes in both DLG1 abundance and localization were also observed in tissues derived 283 
from the FK18B-passage 27 cells (Fig. 2), highlighting the significance of our findings. These results 284 
indicate that viral proteins expression in the context of HPV-18 entire genome is responsible of those 285 
alterations, and, in view of our previous data, E7 or E6/E7 expression is most likely involved. These 286 
results are also relevant in light of DLG1 expression in cervical biopsies. FK-18B-passage 27 cultures 287 
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exhibit morphological alterations suggestive of mild/moderate dysplasia (Steenbergen et al., 1998) 288 
and we previously demonstrated that DLG1 was over-expressed and exhibited altered cellular 289 
distribution in SIL HPV-positive lesions, with a progressive loss from cell contacts (Cavatorta et al., 290 
2004).  291 
Most of the previous studies about HPV interference with cell polarity were focused on high-risk 292 
HPVs. No data were available about polarity proteins expression in general, or specifically for DLG1, 293 
in low-risk HPV associated lesions. Unexpectedly, we also found some changes in DLG1 expression 294 
in the presence of HPV-11 proteins. We observed that raft cultures expressing HPV-11 sequences 295 
exhibit morphological changes suggesting a low-grade dysplasia, albeit to a lesser extent than for 296 
high-risk HPVs (Fig. 1a and 4a) (Thomas et al., 2001; Fang et al., 2006). In organotypic cultures 297 
expressing HPV-11 E7 or E6/E7, DLG1 immunostaining was altered when compared to control 298 
cultures (Fig. 4c). DLG1 was observed throughout the tissue strata, possibly due to changes in cellular 299 
differentiation status (Thomas et al., 2001; Fang et al., 2006). However, unlike the results described 300 
for HPV-18, DLG1 was present at cell borders in cultures expressing HPV-11 proteins, and this may 301 
be relevant considering the different capacity of each virus in transforming cells and in promoting  302 
malignant progression. DLG1 reduction at cell contacts may contribute to alterations in signal 303 
transduction pathways controlling cell proliferation, as part of DLG1 oncosuppressing functions.  304 
Nevertheless, HPV-11 proteins were also capable to induce an increase in DLG1 levels in both 305 
organotypic and monolayer epithelial cell cultures (Fig. 5). It is possible to speculate that this augment 306 
in DLG1 abundance may be a critical conserved viral activity in order to favor virus replication. Some 307 
function conservations between the E6/E7 proteins from high- and low-risk HPV types were shown 308 
(Pim and Banks, 2010) and probably E6/E7 from both HPV could induce molecular mechanisms 309 
involved in DLG1 levels regulation. In addition, infections by low-risk HPV types also induce 310 
unscheduled host DNA synthesis in a fraction of post mitotic, differentiated cells (Cheng et al., 1995, 311 
Jian et al., 1999, McCord, 2014). We observed that HPV-11 E6/E7 induced cyclin A and PCNA 312 
proteins expression in the epithelium suprabasal layer (Fig.3S), although to a lesser extent than that 313 
observed in HPV-18 cultures. It is possible that DLG1 expression and cell cycle progression may be 314 
functionally linked explaining the differences observed in the different conditions analyzed in this 315 
study.  316 
How the abundance of low and high- risk HPV proteins could influence DLG1 expression pattern 317 
during viral cycle is still unknown. However, deregulated viral protein expression might have an 318 
impact on DLG1 expression. This is supported by the observation that in cervical cancer samples, 319 
where HPV oncoproteins expression is deregulated and no viral replication occurs, there is a dramatic 320 
reduction of DLG1 1evels, when comparing with intraepithelial precursors lesions (Cavatorta et al., 321 
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2004). Further studies are needed to clarify this important issue and for a complete comprehension of 322 
HPV associated pathogenesis. 323 
In summary, the data from this study demonstrated that E7 and E6/E7 proteins derived from both 324 
HPV-11 and HPV-18 induce changes in the distribution and abundance of DLG1 polarity protein in 325 
organotypic cultures. The most significant difference was the DLG1 expression at cell contacts, which 326 
may reflect the difference in the pathologies associated with low- or high-risk HPV. Moreover, 327 
alterations in DLG1 expression was also observed in raft cultures bearing the entire HPV-18 genome. 328 
DLG1 protein expression is frequently altered in a variety of human cancers and the results presented 329 
here suggest a role for E7 and E6/E7 proteins in these changes for the HPV-associated neoplastic 330 
lesions.  331 
 332 
Methods 333 
Organotypic raft cultures 334 
Organotypic raft cultures were generated as described elsewhere (Boccardo et al., 2010). Low 335 
passage-pooled neonatal foreskin keratinocytes (LonzaWalkersville) were grown in serum-free 336 
medium (Invitrogen). Cells were infected with the recombinant retroviruses and after 24 h were 337 
selected with the correspondent antibiotic. After 2 days, when 100% of mocked infected controls 338 
were dead, infected cells were used to seed the epithelial raft. Recombinant retroviral vectors 339 
containing HPV-11 E7 and E7/E6 genes were kindly provided by Dennis J. McCance and are 340 
described elsewhere (Guess and McCance, 2005). Recombinant retrovirus vectors containing 341 
untraslated regulatory region (URR)-E7 or -E6/E7 sequences from HPV-18 are described elsewhere 342 
(Boccardo et al., 2004). After 10 days, organotypic raft cultures were harvested for protein or RNA 343 
analysis or fixed for histological investigation as described below.  344 
Organotypic raft cultures from the keratinocyte cell line FKB18B, which harbors the HPV-18 full-345 
length genome were established as previously described (Pinheiro et al., 2014). Briefly, PHK were 346 
transfected with HPV-18 full-length genome (FK18B) and grown during different passages before 347 
raft culture seeding (Steenbergen et al., 1998). 348 
Cell culture, plasmids and transfection 349 
HEK293 epithelial cells were grown in Dulbecco’s modified Eagle’s medium (Gibco) supplemented 350 
with 10% (v/v) fetal bovine serum (PAA). The respective HPV-18 E6 or E7 genes were cloned under 351 
the control of CMV promoter (Facciuto et al., 2014). Plasmids expressing HPV-11 E6 or E7 proteins 352 
were kindly provided (Guess and McCance, 2005). Cells were transfected with the indicated 353 
constructions using calcium phosphate precipitation as described (Matlashewski et al., 1987). 354 
Western Blotting 355 
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Protein extraction from organotypic raft cultures was performed as previously reported (Boccardo et 356 
al., 2004) using extraction buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 0.1mM EDTA, 0.5% 357 
NP40) containing protease inhibitors. HEK293 cells were lysed in ice-cold lysis buffer (50mM Tris-358 
HCl pH 7.5, 150mM NaCl, 1mM EDTA, 1% NP40, 0.5% deoxycolate) containing Halt Protease 359 
Inhibitor single use cocktail (Thermo Scientific Pierce). Subsequently, WB experiments were carried 360 
out as described (Gardiol et al., 1999). Equal amounts of proteins were separated by SDS-PAGE and 361 
transferred to appropriate membranes. Specific protein levels were determined by immunoblot 362 
analysis using mouse monoclonal anti-DLG1 (2D11, Santa Cruz Biotechnology); mouse monoclonal 363 
anti p53 (DO-1, Santa Cruz Biotechnology); rabbit polyclonal anti pRb (M-153, Santa Cruz 364 
Biotechnology) and mouse monoclonal anti-γ tubulin (T6557, Sigma Aldrich). The secondary 365 
antibody used was anti-mouse (NXA931; Amersham GE) coupled to horseradish peroxidase and 366 
detected by chemiluminescence, using the SuperSignal West Pico Chemiluminescent Substrate 367 
reagent (Thermo Scientific Pierce). γ -tubulin was measured as a loading control. Protein band 368 
intensities were quantitated using Image J quantification program. 369 
RNA isolation, cDNA synthesis and RT-PCR  370 
For testing E7 or E6 gene expression, total RNA was extracted using TRIzol Reagent (Life 371 
Technologies) following the manufacturer’s instructions. cDNA was synthesized from 2 µg of RNA 372 
using 200 U MMuLV RevertAid reverse transcriptase (Fermentas) and oligo(dT) primers. cDNA 373 
from each sample was subjected to PCR amplification with specific forward (F) and reverse (R) 374 
primers. HPV-11E6 F: 5’-TTATAGATCTATGGAAAGTAAAGATGCCTCC-3’, R: 5’-375 
TTATAACTTTTAGGGTAACAAGTCTTCCATG-3’; HPV-18E6 F: 5’-376 
TTATAGATCTATGGCGCGCTTTGAGGATCCAAC-3’, R: 5’- 377 
TTATAAGCTTTTATACTTGTGTTTCTCTGCGTC-3’; HPV-11E7 F: 5’- 378 
GTGGACAAACAAGACGCACAA-3’, R: 5’-TGCCCAGCAAAAGGTCTTG TA-3’; HPV-18E7 379 
F: 5’-TGCATGGACCTAAGGCAACA-3’, R: 5’-CTCGTCGGGCTGGTAAATGT-3’. Human 380 
succinate dehydrogenase gene (SDH), used as housekeeping marker, was amplified with SDH-F, 5′-381 
GCACACCCTGTCCTTTGT-3′ and SDH-R, 5′-CACAGTCAGCCTCGTTCA-3′ primers. 382 
Immunohistochemistry 383 
Organotypic raft cultures were harvested, fixed in buffered formalin, embedded in paraffin, cut into 384 
3 µm sections and mounted on pretreated glasses. Sections were stained with hematoxylin and eosin 385 
to observe histology. The immunohistochemistry assays were performed as described previously 386 
(Cavatorta et al., 2004, Gardiol et al., 2006). Briefly, the samples were deparaffinized in xylene and 387 
rehydrated using a graded alcohol series. Endogenous peroxidase activity was blocked by immersing 388 
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sections in 3% hydrogen peroxide in methanol for 20 min. Sections were placed in 10mM Tris-1mM 389 
EDTA buffer (pH 8.3) and heated for 12 min on high power using a conventional microwave oven, 390 
to facilitate antigen retrieval. Samples were allowed to cool down. After blocking nonspecific binding 391 
by addition of normal horse serum (Vectastain ABC Kit; Vector) for 40 min, sections were incubated 392 
with the respective primary antibody overnight at 4°C in a humid chamber. The primary antibodies 393 
anti-DLG1 (2D11, 1:40), anti-pRb (M-153, 1:200) and anti-p53 (DO-1, 1:50) were purchased from 394 
Santa Cruz Biotechnology. The primary anti-cyclin A (NCL-cyclin A) and anti-PCNA (#18-0110) 395 
were purchased from Novocastra and Zymed, respectively. For detection, samples were treated 396 
successively with biotinylated secondary antibody for 30 min and with avidin–biotin peroxidase 397 
complex for a further 30 min at room temperature (DAKO). The reaction was developed using a 398 
diaminobenzidine chromogenic substrate kit for peroxidase (Vector), and sections were 399 
counterstained with hematoxylin. Negative controls were processed as described, except that primary 400 
antibody was omitted.  401 
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Legend to Figures 562 
Figure 1. HPV-18 oncoproteins redistribute and alter subcellular localization of DLG1 in 563 
organotypic raft cultures. 564 
a- Paraffin-embedded sections of the different organotypic rafts cultures were stained with 565 
hematoxylin and eosin in order to show the morphological details of the tissues. Scale Bar: 20 µm. 566 
b- HPV-18 E7 and E6 gene expression transcription was ascertained by RT-PCR with specific 567 
primers. – RT lanes demonstrate the absence of residual contaminating viral DNA in DNase-treated 568 
mRNA samples. 569 
c- HPV-18 E7 and E6 functional protein expression was confirmed by ascertaining the level of the 570 
cellular targets, RB and p53, by Western Blot. γ-tubulin was used as loading control. 571 
d- Analysis of the expression and localization of DLG1 in control, HPV-18 E7 and HPV-18 E6/E7 572 
raft cultures by immunohistochemistry. Representative paraffin-embedded sections of rafts 573 
immunostained with anti-DLG1 (brown staining) and counterstained with haematoxylin are shown. 574 
Blue arrows indicate DLG1 localization at the cell borders in control culture and some areas of the 575 
HPV-18 E7 raft. Red arrows show DLG1 misdistribution from the cell contacts to the cytoplasm in 576 
HPV-18 E7 and E6/E7 cultures. Scale Bar: 20 µm. 577 
 578 
Figure 2. DLG1 pattern of expression is altered in organotypic cultures bearing the full-length 579 
HPV-18 genome. 580 
Analysis of the expression and localization of DLG1 in control and FKB18 (passage 27,p27) raft 581 
cultures by immunohistochemistry. Representative paraffin-embedded sections of rafts 582 
immunostained with anti-DLG1 (brown staining) and counterstained with haematoxylin are shown. 583 
Blue arrows indicate DLG1 localization at the cell borders in control culture. Red arrows show DLG1 584 
misdistribution from the cell contacts to the cytoplasm in HPV-18 entire genome culture. Scale Bar: 585 
20 µm. 586 
 587 
Figure 3. HPV-18 E7 and E6/E7 proteins induce an increase in DLG1 expression levels.  588 
a- Protein extracts from control and HPV-18 E7 or E6/E7 expressing organotypic cultures were 589 
analyzed by WB for DLG1 expression.  590 
b- HEK293 cells were transfected with the corresponding empty or HPV-18 E7 or HPV-18 E6/E7 591 
expressing vectors. After 24 hs, cells were harvested and protein extracts were assessed by WB for 592 
DLG1 levels.  593 
Numbers are folds of band intensity for DLG1 in rafts (a) or cells (b) expressing viral proteins, with 594 
respect to the corresponding control sample (considered as 1). Right panels, densitometry analysis of 595 
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Western blots for DLG1 (mean ± SD, n ≥ 3) showing DLG1 level (DLG1/γ-Tubulin ratio) in rafts (a) 596 
or cells (b) expressing viral proteins, relative to each control sample, set as 1. The intensity of each 597 
band was normalized to γ-tubulin expression, used as loading control. 598 
 599 
Figure 4. HPV-11 E7 and E6/E7 proteins induce a redistribution of DLG1 along the squamous 600 
epithelium in organotypic raft cultures. 601 
a- HPV-11 E7 and E6/E7 induce a thickening of the stratified epithelium and mildly modify tissue 602 
morphology. Paraffin-embedded sections of the different organotypic raft cultures were stained with 603 
hematoxylin and eosin in order to show the morphological details of the tissues. Scale Bar: 20 µm. 604 
b- HPV-11 E7 and E6 gene expression was ascertained by RT-PCR with specific primers. –RT lanes 605 
demonstrate the absence of residual contaminating viral DNA in DNase-treated mRNA samples. 606 
c- Analysis of the expression and localization of DLG1 in control, HPV-11 E7 and HPV-11 E6/E7 607 
raft cultures by immunohistochemistry. Representative paraffin-embedded sections of rafts 608 
immunostained with anti-DLG1 (brown staining) and counterstained with haematoxylin are shown. 609 
Blue arrows indicate DLG1 localization at the cell borders in control, HPV-11 E7 and HPV-11 E6/E7 610 
cultures. Red arrows show cytoplasmic DLG1 expression in HPV-11 E7 and HPV-11 E6/E7 raft 611 
culture. Scale Bar: 20 µm. 612 
 613 
Figure 5: HPV-11 E7 and E6/E7 proteins increase DLG1 expression levels.  614 
a- Protein extracts from epithelial control cultures and from rafts expressing HPV-11 E7 or E6/E7 615 
were analyzed by WB for DLG1 expression. 616 
b- HEK293 cells were transfected with the corresponding empty vector or expressing HPV-11 E7 or 617 
HPV-11 E6/E7 proteins. After 24 hs, cells were harvested and protein extracts were assessed by WB 618 
for DLG1 levels.  619 
Numbers are folds of band intensity for DLG1 in rafts (a) or cells (b) expressing viral proteins, with 620 
respect to the corresponding control sample (considered as 1). Right panels, densitometry analysis of 621 
Western blots for DLG1 (mean ± SD, n ≥ 3) showing DLG1 level (DLG1/γ-Tubulin ratio) in rafts (a) 622 
or cells (b) expressing viral proteins, relative to each control sample, set as 1. The intensity of each 623 
band was normalized to γ-tubulin expression, used as loading control. 624 
 625 
 626 
